M&A Deal Summary

Getinge Acquires Talis Clinical

On December 23, 2021, Getinge acquired internet software and services company Talis Clinical

Acquisition Highlights
  • This is Getinge’s 1st transaction in the Internet Software and Services sector.
  • This is Getinge’s 4th transaction in the United States.
  • This is Getinge’s 1st transaction in Ohio.

M&A Deal Summary

Date 2021-12-23
Target Talis Clinical
Sector Internet Software and Services
Buyer(s) Getinge
Deal Type Add-on Acquisition

Target

Talis Clinical

Streetsboro, Ohio, United States
Talis Clinical is a provider of high acuity cloud-based software solutions. Talis Clinical is based in Streetsboro, Ohio.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Getinge

Gothenburg, Sweden

Category Company
Founded 1904
Sector Medical Products
Employees11,891
Revenue 31.8B SEK (2023)
DESCRIPTION

Getinge is a medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge was founded in 1904 and is based in Gothenburg, Sweden.


DEAL STATS #
Overall 8 of 11
Sector (Internet Software and Services) 1 of 1
Type (Add-on Acquisition) 7 of 10
State (Ohio) 1 of 1
Country (United States) 4 of 7
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-12 Verrix

San Clemente, California, United States

Verrix is a medical device company that is using the most advanced technologies to help protect patients from healthcare-associated infections. Verrix is based in San Clemente, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-31 HPNE

Smithfield, Rhode Island, United States

HPNE provides a comprehensive range of proprietary and distributed products from drug discovery, upstream and downstream processing, to fill-and-finish. HPNE's products assist leading biopharmaceutical and biotechnology players in the production of monoclonal antibodies, vaccines, cell and gene therapies and other next-generation therapies. HPNE was founded in and is based in Smithfield, Rhode Island.

Buy $290M